Successful outcomes with oral fluoroquinolones combined with rifampicin in the treatment of Mycobacterium ulcerans: an observational cohort study
about
Drugs for treating Buruli ulcer (Mycobacterium ulcerans disease)Mycobacterium ulcerans treatment--can antibiotic duration be reduced in selected patients?Efficacy of Rifampin Plus Clofazimine in a Murine Model of Mycobacterium ulcerans DiseaseSterilizing Activity of Fully Oral Intermittent Regimens against Mycobacterium Ulcerans Infection in MiceCorticosteroid use for paradoxical reactions during antibiotic treatment for Mycobacterium ulcerans.Corticosteroid-induced immunosuppression ultimately does not compromise the efficacy of antibiotherapy in murine Mycobacterium ulcerans infection.Mycobacterium ulcerans disease: experience with primary oral medical therapy in an Australian cohort.Incidence, clinical spectrum, diagnostic features, treatment and predictors of paradoxical reactions during antibiotic treatment of Mycobacterium ulcerans infections.Clinical efficacy of Rifampicin and Streptomycin in combination against Mycobacterium ulcerans infection: a systematic review.Pre-emptive steroids for a severe oedematous Buruli ulcer lesion: a case report.Mycobacterium ulcerans infection: evolution in clinical management.Epidemiology and management of Buruli ulcer.Management of BU-HIV co-infection.Antibiotic Complications During the Treatment of Mycobacterium ulcerans Disease in Australian Patients.Exploration of a standard treatment for Buruli ulcer through a comprehensive analysis of all cases diagnosed in Japan.Increasing Experience with Primary Oral Medical Therapy for Mycobacterium ulcerans Disease in an Australian Cohort.Wound healing: Natural history and risk factors for delay in Australian patients treated with antibiotics for Mycobacterium ulcerans disease.Buruli Ulcer: a Review of the Current Knowledge
P2860
Q24186073-A83FBC9F-64CB-471B-8E7D-3BA95AC7A514Q28543227-452753FF-1A86-4A81-AD37-9A63E1259D82Q28552524-87513564-42C2-4B1C-8369-100A6B5A3A49Q28552736-C90482B3-3611-4A79-ABFE-1A6A86F844C1Q34431496-76A12781-E2C8-4E7F-98D9-3B6895D05D17Q34500901-8B343D55-830B-490B-968F-257F4B7A778BQ34855365-1AECE05C-4B31-4C9C-931F-6CBD3515185FQ34978950-28DC4FDB-C2D0-4E53-BE31-CF78F8D34C0AQ35084312-B277B230-F8EF-466B-BA82-93A6BB904A75Q35595678-88F30065-9501-45A0-BD2D-0B65000C344FQ38044475-BEE0FDD7-3BB2-4C5B-94E0-B3656B08D96DQ38219419-823C9AF4-0088-4785-91CF-54C601967CE6Q38221645-3D041271-B2DA-45CE-B9CE-F5A3C226FCA6Q38741481-8BD308DB-D581-4653-BE96-9A3FAAD2A88EQ39496473-51BC958E-AEF2-45EA-A2CE-E3CA0D7BC2A2Q40789030-2345EA33-DC91-4034-8020-50C4CB840F1EQ51738497-1182A1DA-B2E8-402F-BCDB-E7957DD494D6Q59132198-E818BAF8-0D85-435C-8E4B-0CC9D3FA4727
P2860
Successful outcomes with oral fluoroquinolones combined with rifampicin in the treatment of Mycobacterium ulcerans: an observational cohort study
description
2012 nî lūn-bûn
@nan
2012 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Successful outcomes with oral ...... an observational cohort study
@ast
Successful outcomes with oral ...... an observational cohort study
@en
Successful outcomes with oral ...... an observational cohort study
@nl
type
label
Successful outcomes with oral ...... an observational cohort study
@ast
Successful outcomes with oral ...... an observational cohort study
@en
Successful outcomes with oral ...... an observational cohort study
@nl
prefLabel
Successful outcomes with oral ...... an observational cohort study
@ast
Successful outcomes with oral ...... an observational cohort study
@en
Successful outcomes with oral ...... an observational cohort study
@nl
P2093
P2860
P1476
Successful outcomes with oral ...... an observational cohort study
@en
P2093
Aaron Walton
Andrew Hughes
Anthony McDonald
Ian Holten
Mike Robson
N Deborah Friedman
Peter Callan
P2860
P356
10.1371/JOURNAL.PNTD.0001473
P407
P577
2012-01-17T00:00:00Z